Abstract:Chronotype, an individual's preferred sleep-wake timing, is influenced by sex and age. Men sometimes report a later chronotype than women and older age is associated with earlier chronotype. The sex-related changes in chronotype coincide with puberty and menopause. However, the effects of sex hormones on human chronotype remain unclear. To examine the impact of 3 months of gender-affirming hormone therapy (GAHT) on chronotype in transgender persons, this study used data from 93 participants from the prospective RESTED cohort, including 49 transmasculine (TM) participants starting testosterone and 44 transfeminine (TF) participants starting estrogens and antiandrogens. Midpoint of sleep and sleep duration were measured using the ultra-short Munich ChronoType Questionnaire (μMCTQ). After 3 months of GAHT, TM participants' midpoint of sleep increased by 24 minutes (95% CI: 3 to 45), whereas TF participants' midpoint of sleep decreased by 21 minutes (95% CI: −38 to −4). Total sleep duration did not change significantly in either group. This study provides the first prospective assessment of sex hormone use and chronotype in transgender persons, showing that GAHT can change chronotype in line with cisgender sex differences. These findings provide a basis for future studies on biological mechanisms and clinical consequences of chronotype changes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the impact of Gender - Affirming Hormone Therapy (GAHT) on the chronotype of transgender people. Specifically, the study focuses on the changes in the midpoint of sleep and sleep duration of transgender people after 3 months of using Gender - Affirming Hormone Therapy. ### Research Background The human circadian rhythm system regulates 24 - hour behavioral and physiological processes. These circadian rhythms are regulated by the central brain clock located in the Suprachiasmatic Nucleus (SCN) of the hypothalamus and synchronize multiple peripheral clocks throughout the body. The molecular mechanism of the circadian rhythm is the transcriptional - translational feedback loop of core clock genes, with an intrinsic period of approximately 24 hours. The variability of the circadian rhythm is mainly determined by genetic variation and environmental factors, and is also affected by age and gender. ### Research Objectives This study aims to explore the impact of Gender - Affirming Hormone Therapy on the chronotype of transgender people, especially the changes in the midpoint of sleep and sleep duration. The research hypotheses are: - Trans - male (TM) users will shift their chronotype from an early type to a late type and have a shortened sleep duration after 3 months of using testosterone. - Trans - female (TF) users will shift their chronotype from a late type to an early type and have an extended sleep duration after 3 months of using estrogen and anti - androgen. ### Research Methods - **Research Population**: Participants were from the RESTED study, a prospective cohort study investigating the impact of Gender - Affirming Hormone Therapy on sleep and mood. The participants included 49 trans - males (TM) and 44 trans - females (TF), who were surveyed by questionnaires at baseline and 3 months later respectively. - **Data Collection**: The Ultra - Short Munich Chrono - type Questionnaire (µMCTQ) was used to measure the midpoint of sleep and sleep duration. - **Statistical Analysis**: Linear mixed - effects models were used for data analysis, taking into account the effects of repeated measurements and working status and other factors. ### Main Results - **Trans - male Group**: In the unadjusted model, the midpoint of sleep in the TM group was delayed by 20 minutes after 3 months; it was delayed by 22 minutes in the adjusted model; and it was delayed by 30 minutes in the sensitivity analysis. There was no significant change in the sleep duration of the TM group. - **Trans - female Group**: In the adjusted model, the midpoint of sleep in the TF group was advanced by 21 minutes after 3 months; it was advanced by 17 minutes in the sensitivity analysis. There was no significant change in the sleep duration of the TF group. ### Conclusions This study is the first to prospectively evaluate the impact of Gender - Affirming Hormone Therapy on the chronotype of transgender people. The results show that Gender - Affirming Hormone Therapy can change the chronotype, making it consistent with the gender differences of cis - gender people. These findings provide a basis for future research on the biological mechanisms and clinical consequences of circadian rhythm changes.

Chronotype changes after sex hormone use: A prospective cohort study in transgender users of gender-affirming hormones

Chronotype, social jetlag and sleep loss in relation to sex steroids

Changes in affect variability after starting gender-affirming hormone therapy

Association of genetically determined chronotype with circulating testosterone: a Mendelian randomization study

Effects of gender affirming hormone treatment in transgender individuals – a retrospective cohort study

Effects of gender‐affirming hormone therapy on lower urinary tract symptoms and sexual function among transgender individuals

1187 Non-24-hour Sleep-Wake Disorder in Transgender Male Receiving Exogenous Testosterone

Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study

Testosterone administration affects H-MRS metabolite spectra in transgender men.

Chronotype in relation to shift work: A cohort study among 37,731 female nurses

0188 Impact of the Menarcheal Transition on Sleep in Biological Females

Chronotype in relation to free and total testosterone in men

Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria

The influences of sleep duration, chronotype, and nightwork on the ovarian cycle

Impact of Distinct Anti-Androgen Exposures on the Plasma Metabolome in Feminizing Gender-Affirming Hormone Therapy

Association of sleep duration, chronotype, social jetlag, and sleep disturbance with phenotypic age acceleration: A cross-sectional analysis

Expected vs. perceived effects of gender-affirming hormone therapy among transmasculine adolescents

Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female Transsexuals

Insulin sensitivity, body composition and bone mineral density after testosterone treatment in transgender youth with and without prior GnRH agonist therapy

Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review

Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals